This article also says that another trial that were included in previous meta-analyses should probably also be excluded and once all that's it's unlikely the meta-analysis will show an effect:

As these two papers1,6 were the only studies included in that meta-analysis to demonstrate an independently significant reduction in mortality, the revision will probably show no mortality benefit for ivermectin.